Alphabet Inc’s Dianthus Therapeutics DNTH Stock Holding History

Alphabet Inc’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-208,697	Closed	-$8.21M	–	32
2025 Q3	$8.21M	Hold	208,697	–	–	0.34%	18
2025 Q2	$3.89M	Hold	208,697	–	–	0.18%	20
2025 Q1	$3.79M	Hold	208,697	–	–	0.24%	22
2024 Q4	$4.55M	Hold	208,697	–	–	0.26%	18
2024 Q3	$5.71M	Hold	208,697	–	–	0.31%	20
2024 Q2	$5.4M	Hold	208,697	–	–	0.27%	22
2024 Q1	$6.26M	Hold	208,697	–	–	0.25%	23
2023 Q4	$2.17M	Hold	208,697	–	–	0.1%	30
2023 Q3	$2.85M	Buy	208,697 +1	+0%	+$13	0.18%	25
2023 Q2	$2.54M	Hold	208,696	–	–	0.14%	30
2023 Q1	$2.64M	Hold	208,696	–	–	0.15%	29
2022 Q4	$1.34M	Hold	208,696	–	–	0.08%	42
2022 Q3	$4.71M	Hold	208,696	–	–	0.24%	32
2022 Q2	$4.01M	Hold	208,696	–	–	0.22%	36
2022 Q1	$9.68M	Hold	208,696	–	–	0.31%	30
2021 Q4	$14.8M	Hold	208,696	–	–	0.36%	32
2021 Q3	$24.3M	Hold	208,696	–	–	0.58%	19
2021 Q2	$32.7M	Hold	208,696	–	–	0.67%	17
2021 Q1	$39.5M	Hold	208,696	–	–	1.59%	13
2020 Q4	$26.2M	Hold	208,696	–	–	1.26%	14
2020 Q3	$22.7M	Hold	208,696	–	–	1.07%	9
2020 Q2	$25.1M	Hold	208,696	–	–	1.16%	8
2020 Q1	$21M	Hold	208,696	–	–	1.38%	8
2019 Q4	$50.6M	Hold	208,696	–	–	3.06%	6
2019 Q3	$34.3M	Hold	208,696	–	–	1.03%	5
2019 Q2	$49.3M	Hold	208,696	–	–	0.93%	5
2019 Q1	$55M	Hold	208,696	–	–	2.84%	5
2018 Q4	$19M	Hold	208,696	–	–	2.25%	9
2018 Q3	$40.1M	Hold	208,696	–	–	3.84%	7
2018 Q2	$45.1M	Buy	+208,696	New	+$47.1M	3.79%	6

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alphabet Inc's DNTH Position: Q4 2025 in Review

Alphabet Inc sold out of Dianthus Therapeutics (DNTH) in Q4 2025, closing a stake of 208,697 shares — an estimated $8.21M sold.

Alphabet Inc first reported a position in DNTH in Q2 2018 and held it in 30 quarters. The position peaked at $55M in Q1 2019. 165 funds tracked by Wall St. Rank hold DNTH as of Q4 2025.

Alphabet Inc reported no remaining Dianthus Therapeutics position as of Q4 2025 after selling out during the quarter.
Alphabet Inc sold 208,697 Dianthus Therapeutics shares in Q4 2025, an estimated $8.21M.
Alphabet Inc first reported a position in Dianthus Therapeutics in Q2 2018 and held it in 30 quarters.
Alphabet Inc's Dianthus Therapeutics position peaked at $55M in Q1 2019.
165 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q4 2025.

Based on Alphabet Inc's 13F filing for Q4 2025, filed 13 Feb 2026.